Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 02, 2023

SELL
$1.06 - $1.97 $8,309 - $15,442
-7,839 Reduced 20.44%
30,515 $34,000
Q4 2022

Feb 10, 2023

BUY
$1.4 - $25.4 $2,100 - $38,100
1,500 Added 4.07%
38,354 $56,000
Q2 2022

Aug 15, 2022

SELL
$12.3 - $27.3 $130,995 - $290,745
-10,650 Reduced 22.42%
36,854 $51,000
Q1 2022

Jun 30, 2022

SELL
$16.6 - $32.3 $54,431 - $105,911
-3,279 Reduced 6.46%
47,504 $123,000
Q4 2021

Feb 15, 2022

BUY
$29.9 - $61.2 $22,245 - $45,532
744 Added 1.49%
50,783 $152,000
Q3 2021

Oct 29, 2021

SELL
$51.4 - $68.2 $158,363 - $210,124
-3,081 Reduced 5.8%
50,039 $275,000
Q2 2021

Aug 16, 2021

BUY
$44.1 - $84.0 $2.34 Million - $4.46 Million
53,120 New
53,120 $389,000

Others Institutions Holding BNGO

About Bionano Genomics, Inc.


  • Ticker BNGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 290,140,000
  • Market Cap $81.2M
  • Description
  • Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel...
More about BNGO
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.